Literature DB >> 26328593

Diagnosis of ovarian cancer.

Sudha Sundar1, Richard D Neal2, Sean Kehoe3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26328593     DOI： 10.1136/bmj.h4443

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  33 in total

1.  Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.

Authors:  Meng Gao; Yanyan Ma; Robert C Bast; Yue Li; Lu Wan; Yanping Liu; Yingshuo Sun; Zhenghui Fang; Lining Zhang; Xiaoyan Wang; Zengtao Wei
Journal:  Med Oncol       Date:  2016-06-08       Impact factor: 3.064

2.  Enhancing delivery of small molecule and cell-based therapies for ovarian cancer using advanced delivery strategies.

Authors:  Joanne O'Dwyer; Roisin E O'Cearbhaill; Robert Wylie; Saoirse O'Mahony; Michael O'Dwyer; Garry P Duffy; Eimear B Dolan
Journal:  Adv Ther (Weinh)       Date:  2020-08-16

Review 3.  Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?

Authors:  Julie L Hentze; Claus K Høgdall; Estrid V Høgdall
Journal:  Mol Clin Oncol       Date:  2019-01-11

4.  Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin.

Authors:  Qia Xu; Yun Liu; Shenyi Wang; Jing Wang; Liwei Liu; Yin Xu; Yide Qin
Journal:  BMC Cancer       Date:  2022-06-08       Impact factor: 4.638

Review 5.  Role of biomarkers for early detection of ovarian cancer recurrence.

Authors:  Pierluigi Giampaolino; Virginia Foreste; Luigi Della Corte; Claudia Di Filippo; Giuseppe Iorio; Giuseppe Bifulco
Journal:  Gland Surg       Date:  2020-08

Review 6.  Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.

Authors:  Marta Szajnik; Małgorzata Czystowska-Kuźmicz; Esther Elishaev; Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2016-06-23       Impact factor: 5.225

Review 7.  Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer.

Authors:  Mei He; Yong Zeng
Journal:  J Lab Autom       Date:  2016-05-23

Review 8.  Genetics and biological markers in urachal cancer.

Authors:  Mark A Behrendt; Bas W G van Rhijn
Journal:  Transl Androl Urol       Date:  2016-10

Review 9.  Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis.

Authors:  Quan Zhou; Wei Li; Bingjie Leng; Wenfei Zheng; Ze He; Manzhen Zuo; Aihua Chen
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

10.  Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma.

Authors:  Zhiwen Shi; Qingguo Zhao; Bin Lv; Xinyu Qu; Xiao Han; Hongyan Wang; Junjun Qiu; Keqin Hua
Journal:  Clin Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.